JAMES DAVID BRANDT, M.D.
Medical Practice in Sacramento, CA
License number
California G054094
Category
Medical Practice
Type
Ophthalmology
License number
California MD-041308E
Category
Medical Practice
Type
Ophthalmology
License number
California 51273
Category
Medical Practice
Type
Ophthalmology
Address
Address
4860 Uc Davis Medical Center - Ophthalmology STE 2400, Sacramento, CA 95817
Phone
(916) 734-6818
(916) 734-0411 (Fax)
(916) 734-0411 (Fax)
Professional information
Dr. James D Brandt, Sacramento CA - MD (Doctor of Medicine)
Address:
UC Davis Eye Center
4860 Y St STE 2400, Sacramento 95817
(916) 734-6602 (Phone)
4860 Y St STE 2400, Sacramento 95817
(916) 734-6602 (Phone)
Hospitals:
UC Davis Eye Center
4860 Y St STE 2400, Sacramento 95817
4860 Y St STE 2400, Sacramento 95817
Education:
Medical Schools
Harvard Medical School
Graduated: 1982
Harvard Medical School
Graduated: 1982
James David Brandt, Sacramento CA
Specialties:
Ophthalmologist
Address:
4860 Y St, Sacramento, CA 95817
Education:
Harvard Medical School - Doctor of Medicine
Wills Eye Hospital - Fellowship - Glaucoma
Massachusetts General Hospital - Fellowship - Research
Los Angeles County-USC Medical Center - Residency - Ophthalmology
Wills Eye Hospital - Fellowship - Glaucoma
Massachusetts General Hospital - Fellowship - Research
Los Angeles County-USC Medical Center - Residency - Ophthalmology
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology
James David Brandt, Sacramento CA
Specialties:
Ophthalmology
Work:
Ucdmc, Lawrence J. Ellison Ambulatory Care Center
4860 Y St, Sacramento, CA 95817
4860 Y St, Sacramento, CA 95817
Education:
Harvard University(1982)
Class Of Glaucoma Drugs To Enhance Aqueous Humor Outflow And Lower Intra-Ocular Pressure
US Patent:
2002017, Nov 28, 2002
Filed:
Apr 26, 2002
Appl. No.:
10/134099
Inventors:
Martha O'Donnell - Davis CA, US
James Brandt - Sacramento CA, US
James Brandt - Sacramento CA, US
Assignee:
The Regents of the University of California, a California Corporation
International Classification:
A61K031/192
US Classification:
514/569000
Abstract:
Elevated intra-ocular pressure is reduced by administration directly to the eye of compounds that activate the Cl and K channels of the trabecular meshwork and/or Schlemm's canal endothelial cells of the mammalian eyes. Intra-ocular pressure may further be reduced by the co-administration of compounds that inhibit function of a Na—K—2Cl co-transporter mechanism of the trabecular meshwork and/or Schlemm's canal endothelial cells. These compounds are useful in treatment of diseases of the eye associated with elevated intra-ocular pressure, such as ocular hypertension and glaucoma. A screening method is provided to discover additional compounds with utility for lowering intra-ocular pressure by substantially activating the Cl and K channels.